Synthomer Dividends - SYNT

Synthomer Dividends - SYNT

[ADVERT]
Best deals to access real time data!
Level 2 Basic
Monthly Subscription
for only
£62.08
Silver
Monthly Subscription
for only
£17.37
UK/US Silver
Monthly Subscription
for only
£30.59
VAT not included
Stock Name Stock Symbol Market Stock Type
Synthomer Plc SYNT London Ordinary Share
  Price Change Price Change % Stock Price Last Trade
-14.80 -3.02% 475.40 16:29:56
Open Price Low Price High Price Close Price Previous Close
479.40 475.00 482.80 475.40 490.20
more quote information »
Industry Sector
CHEMICALS

Synthomer SYNT Dividends History

Announcement Date Type Currency Dividend Amount Period Start Period End Ex Date Record Date Payment Date Total Dividend Amount
05/08/2021InterimGBX8.731/12/202031/12/202107/10/202108/10/202104/11/20210
04/03/2021FinalGBX8.631/12/201931/12/202003/06/202104/06/202105/07/202111.6
14/10/2020InterimGBX331/12/201931/12/202022/10/202023/10/202010/11/20200
06/08/2019InterimGBX431/12/201831/12/201903/10/201904/10/201905/11/20194
04/03/2019FinalGBX9.131/12/201731/12/201806/06/201907/06/201905/07/201913.1
06/08/2018InterimGBX431/12/201731/12/201804/10/201805/10/201806/11/20180
01/03/2018FinalGBX8.531/12/201631/12/201707/06/201808/06/201806/07/201812.2
08/08/2017InterimGBX3.731/12/201631/12/201705/10/201706/10/201706/11/20170
06/03/2017FinalGBX7.831/12/201531/12/201608/06/201709/06/201706/07/201711.3
09/08/2016InterimGBX3.531/12/201531/12/201606/10/201607/10/201604/11/20160
02/03/2016FinalGBX5.431/12/201431/12/201502/06/201603/06/201604/07/20168.6
11/08/2015InterimGBX3.231/12/201431/12/201508/10/201509/10/201505/11/20150
26/02/2015SpecialGBX7.831/12/201331/12/201404/06/201505/06/201503/07/20150
26/02/2015FinalGBX4.831/12/201331/12/201404/06/201505/06/201503/07/201515.6
11/08/2014InterimGBX331/12/201331/12/201408/10/201410/10/201406/11/20140
28/02/2014FinalGBX3.631/12/201231/12/201304/06/201406/06/201404/07/20146
13/08/2013InterimGBX2.431/12/201231/12/201309/10/201311/10/201307/11/20130
15/03/2013FinalGBX3.331/12/201131/12/201205/06/201307/06/201305/07/20135.5
28/08/2012InterimGBX2.231/12/201131/12/201210/10/201212/10/201208/11/20120

Top Dividend Posts

DateSubject
04/11/2021
18:45
james dean: Another good day for the wife when her dividend arrived this morning.
29/10/2021
14:50
nerja: Interactive investors winter list, Lio, Safe, Xpp, Hlma, Adm, Synt, SXs, Hils, It’s performed very well over the last 8 winters
06/8/2021
18:35
mauricemonkey: I’d be bothered if that was all they made, but it isn’t. PE(F) of 10 seems low and a not terrible divi while I await the rerate. I think Berenberg have got this wrong. Time will tell obviously.
12/7/2021
15:43
philanderer: Peel Hunt upgrades Synthomer Peel Hunt has upgraded chemicals business Synthomer (SYNT) as momentum builds in its end markets and M&A potential arises. Analyst Jolyon Wellington upgraded his recommendation from ‘add’ to ‘buy’ and increased the target price from 538p to 600p on the stock, which closed up 3.6%, or 18p, at 521p on Friday. ‘Synthomer’s end markets appear to be continuing strong momentum, and we believe upgrades to financial year 2022 [guidance] are possible at the forthcoming interims,’ he said. ‘With strong cashflow generation paying down debt, and new chief executive Michael Willome confirmed, M&A is back on the cards.’ He added the combination of Willome, an M&A specialist, and a ‘replenished balance sheet’ means the group could spend up to £1bn on acquisitions. HTTPS://citywire.co.uk/wealth-manager/news/share-tips-thg-st-modwen-bunzl-mj-gleeson-and-synthomer/a1529614#i=6
09/7/2021
07:32
tomps2: Richard Leonard mentions Synthoma (SYNT) in the latest PIWORLD Interview at 17m20s. Watch the video here: Https://www.piworld.co.uk/education-videos/a-piworld-interview-richard-leonard-what-hes-been-buying-july-2021/ Or listen to the podcast here: Https://piworld.podbean.com/e/a-piworld-interview-richard-leonard-what-he-s-been-buying-july-2021/
25/6/2021
07:39
tomps2: Daniel Jones ‘slams’ Synthomer (SYNT) in the latest PIWORLD/Stockopedia StockSlam at 1h04m40s Watch the video here: Https://www.piworld.co.uk/education-videos/the-stockopedia-piworld-virtual-stockslam-june-2021/ Or listen to the podcast here: Https://piworld.podbean.com/e/the-stockopediapiworld-virtual-stockslam-june-2021/
02/6/2021
13:24
philanderer: xd tomorrow morning for the 8.6p dividend
20/4/2021
10:47
sphere25: ELM continuing to attract offers then with what appears to be rather specific commentary suggesting a mix of cash and shares being offered at over 200p. That normally suggests it is more than speculation so surely ELM will be putting out an RNS at some point today. Just wonder if SYNT might pop on that for a very quick one (exit if no major movement). Looking further out, there were also rumours about CVC tabling an offer a short while back - will they or someone else come and have a look in here? All imo DYOR
22/2/2021
14:11
philanderer: SYNT well in demand today :-O Results due on 4th march
15/9/2019
08:21
robow: GREAT IDEAS 10 | SHARES | 12 September 2019 Chemicals firm Synthomer (SYNT) looks very tempting at the current price following a big sell-off over the past year. The firm’s share price dropped from around 530p a year ago to 280p last month and saw the stock trade on nearly its lowest rating in a decade, while its level of debt compared to how much it’s earning is expected to double. But with the business on the cusp of global expansion as it aims to keep up with soaring demand for its products, investors with a long-term view may want to take advantage of the firm’s cheap valuation. The chemicals sector has historically been a good place to invest with significant share price gains over the past decade and occasionally generous dividends. But chemicals companies have been caught up by concerns over a global economic slowdown in the past year, and some in the market think this may feed into weaker demand for chemicals products. Synthomer has tried to expand significantly to keep up with demand for its speciality products, sought after due to many factors such as urbanisation, ageing demographics and stricter legislation. The firm supplies aqueous polymers to companies, which The company should benefit from capacity expansion and a deal to boost its position in the US and Europe The outlook is looking brighter for Synthomer Synthomer is also forecast by analysts at Canaccord and Numis to have a much stronger second half of this year as market conditions are set to improve. That combined with its completed upgrades to facilities in Germany and Malaysia means the firm will have greater capacity to meet demand for its products. Its net debt-to-earnings ratio is expected to increase next year to between 2.2 and 3-times as the Omnova deal is completed. But Synthomer has a clear plan to get this down below 2-times by the end of 2021. Its management team has a disciplined approach to M&A, with a ‘conservative capital’ policy meaning it’s unlikely to ever be reckless in the pursuit of growth. help create new products and boost the performance of existing ones, such as footwear insoles, condoms, packaging tapes, carpets and waterproofing products. While strong on the consumer side, investors had questioned Synthomer’s growth prospects given its lack of real penetration into the industrial market. But the proposed deal to acquire Omnova Solutions, an American speciality chemicals business operating in sectors like construction and oil and gas, could make the market reappraise Synthomer. As well as the US, Omnova has manufacturing and technical facilities in Europe, Thailand and China. Analysts at UBS believe the acquisition will help Synthomer sell more products in the US, and help it expand its facilities in Europe. SYNT is also forecast by analysts at Canaccord and Numis to have a much stronger second half of this year as market conditions are set to improve. That combined with its completed upgrades to facilities in Germany and Malaysia means the firm will have greater capacity to meet demand for its products. Its net debt-to-earnings ratio is expected to increase next year to between 2.2 and 3-times as the Omnova deal is completed. But Synthomer has a clear plan to get this down below 2-times by the end of 2021. Its management team has a disciplined approach to M&A, with a ‘conservative capital’ policy meaning it’s unlikely to ever be reckless in the pursuit of growth. help create new products
ADVFN Advertorial
Your Recent History
LSE
SYNT
Synthomer
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211128 22:05:21